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Cloning Strain construction
Primers csgD_FLAG_F and csgD_FLAG_R were used for the amplification of a PCR fragment with the kanamycin resistance cassette flanked by FRT sites and the 3xFLAG sequence. The primers also include 5'-end homologues to the 3'-end of csgD. The PCR fragment was then transformed and recombined into BW25113/pKD46 as described previously (7).
The remaining strains constructed in this work were constructed using P1 phage transduction as described by Miller (11) . SØ928Δ5 was constructed in serial, one knock-out at a time (except for omrA and omrB which are genomically adjacent). After transduction, pCP20 was transformed into the resulting strain to remove the resistance cassette leaving only a FRT-scar site. The procedure was repeated until all 5 sRNAs were knocked-out in the same strain and all resistance cassettes had been removed.
Plasmid construction pNDM-omrA
The omrA gene was amplified from SØ928 chromosomal DNA using the primers omrA_AatII_F and omrA_BamHI_R. The PCR product was digested with AatII and BamHI and inserted into pNDM220. This plasmid expresses OmrA under lac promoter control (i.e. IPTG inducible).
pBAD-csgD micM
The plasmid was constructed in a two-step PCR. The first PCR amplified a region containing the coding sequence of micM and 29 bps downstream of its terminator using the primers MicM_csgD_F and MicM_Pst_R with the genome of SØ928 as template (PCR1). Since the forward primer contains a 5'-end complementary to the 63 th to 87 th nucleotides of the csgD coding sequence, PCR1 was used as reverse primer for amplification of the pBAD promoter together with the 5' UTR of csgD using the primers csgD_BamHI_F and PCR1 with the plasmid pBAD-csgD FLAG as template (PCR2). The resulting PCR product was digested with BamHI and PstI, and inserted into pBAD33. This plasmid expresses the 5' UTR and 87 coding nucleotides of csgD followed by the coding sequence and terminator of small RNA micM to stabilize the 3'end under BAD promoter (i.e. arabinose inducible). The plasmid was sequence verified using primers pBAD33_F and pBAD33_R.
pBAD-csgD micM and pBAD-csgD FLAG mutants
The mutant plasmids were constructed in a two-step PCR. The first PCR introduced the mutations using reverse primers with the desired mutations (csgD_ΔA/U, csgD_GGGG, csgD_Δstem, csgD_Forced+C or csgD_Forced+G) in combination with forward primer csgD_BamHI_F and with pBAD-csgD MicM as template (PCR3-PCR7). The resulting products were used in separate reactions as forward primers in combination with pBAD33_R and either pBAD-csgD micM or pBAD-csgD FLAG as templates (PCR8). The resulting PCR products were digested with BamHI and PstI, and inserted into pBAD33. The resulting constructs are thus identical with the pBAD-csgD micM or pBAD-csgD FLAG except for the mutations introduced by the respective reverse primers used for PCR3-PCR7. Plasmids were sequence verified using primers pBAD33_F and pBAD33_R.
